Two studies find the genome-editing technique works best when cells have a faulty DNA-damage response that’s frequently present in cancers.  

Researchers have developed a variety of techniques to detect when CRISPR misses the mark.

Researchers identify antibodies for two commonly used Cas9 proteins in human blood. Investors take notice.

Fifty years ago, Arthur Kornberg announced to reporters that his team had synthesized functional DNA.

From single-cell analysis to whole-genome sequencing, this year's best new products shine on many levels.

The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.

Scientists extend the capabilities of the CRISPR-Cas system to include precise manipulations of RNA sequences in human cells.

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

Professionals in the genetics field generally support editing the genomes of somatic cells, mirroring public opinion, but diverge from nonexperts when it comes to germline editing.